A detailed history of Jump Financial, LLC transactions in Humacyte, Inc. stock. As of the latest transaction made, Jump Financial, LLC holds 93,763 shares of HUMA stock, worth $315,981. This represents 0.01% of its overall portfolio holdings.

Number of Shares
93,763
Previous 327,622 71.38%
Holding current value
$315,981
Previous $1.78 Million 73.46%
% of portfolio
0.01%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
$3.46 - $5.81 $809,152 - $1.36 Million
-233,859 Reduced 71.38%
93,763 $473,000
Q3 2024

Nov 14, 2024

BUY
$5.11 - $9.46 $855,030 - $1.58 Million
167,325 Added 104.38%
327,622 $1.78 Million
Q2 2024

Aug 14, 2024

BUY
$2.87 - $9.1 $460,052 - $1.46 Million
160,297 New
160,297 $769,000
Q2 2022

Aug 09, 2022

BUY
$3.21 - $7.86 $48,471 - $118,686
15,100 New
15,100 $48,000

Others Institutions Holding HUMA

About Humacyte, Inc.


  • Ticker HUMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,007,000
  • Market Cap $347M
  • Description
  • Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...
More about HUMA
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.